key: cord-1048053-02b37kjw authors: Lau, Jillian SY.; Buntine, Paul; Price, Melanie; Darzins, Peteris; Newnham, Evan; Connell, Ailie; Chean, Roy; Edwards, Glenn; Guy, Stephen title: SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia date: 2021-04-13 journal: Infect Dis Health DOI: 10.1016/j.idh.2021.03.004 sha: e221ff812fd924a82e704accbb463790760abd49 doc_id: 1048053 cord_uid: 02b37kjw BACKGROUND: Healthcare workers (HCW) are exposed to an increased risk of COVID-19 through direct contact with patients and patient environments. We calculated the; seroprevalence of SARS-CoV-2 in HCW at Eastern Health, a tertiary healthcare network in Victoria, and assessed associations with demographics, work location and role. METHODS: A cross-sectional cohort study of HCW at Eastern Health was conducted. Serum was analysed for the presence of antibodies to SARS-CoV-2, and all participants completed; an online survey collecting information on demographics, place of work, role, and exposures; to COVID-19. Seroprevalence was calculated as the proportion participants with SARS-CoV-2; antibodies out of all tested individuals. RESULTS: The crude seroprevalence of SARS-CoV-2 antibodies in this study was 2.17% (16/736). Thirteen of the 16 (81.2%) positive cases had previously been diagnosed with COVID-19 by PCR: the seroprevalence in the group not previously diagnosed with COVID by PCR was 0.42% (3/720). Having direct contact with COVID-19 patients did not increase the likelihood of having positive serology. A prior history of symptoms consistent with COVID-19 was associated with a higher likelihood of having positive serology (OR 17.2, p=0.006, 95%CI: 2.25-131.55). CONCLUSION: Our calculated seroprevalence of 2.17% is higher than estimated in the general Australian population, but lower than that reported in HCW internationally. The; majority of those with positive serology in our study had previously been diagnosed with COVID-19 by PCR based testing. Seropositivity was not associated with interaction with COVID-19 positive patients, highlighting effective infection prevention and control practices within the workplace. The Australian experience with COVID-19 is notable for relatively low case numbers compared to many other countries. Daily new infections peaked at 746 on the 20th July 2020 (1) in a second wave of infections. As of the 17th February 2021, 4170 of Victoria's Health care workers (HCW) have been infected with SARS-CoV-2, with up to 73% of infections thought to be acquired in the workplace (2) . Eastern Health (EH) is a tertiary public health network in Melbourne, comprising three acute hospitals and four subacute health centres, servicing a catchment population of >800,000. Since March 2020, EH has provided inpatient care for over 150 patients infected with SARS-CoV-2. In addition, staff were seconded to manage unwell residents at aged care facilities, where a disproportionately high number of cases were diagnosed, significantly contributing to COVID-19 mortality in Australia (3) . As of January 2021, there had been 61 known infections in EH staff members (diagnosed by SARS-CoV-2 PCR) and 371 HCW have been required to undertake a 14-day period of furlough and self-isolation, after identification as a close contact of a positive case. One in 17 people working in Australia is a registered healthcare practitioner (4) , and this does not include workers within healthcare settings such as support, security, cleaning, maintenance and catering staff. HCWs may be at an increased risk of infection due to direct contact with patients and patient environments, and increased frequency of contact with other colleagues in the 'high risk' hospital setting. Infections in HCW may be more likely to be diagnosed due to different case definitions and testing criteria, including asymptomatic J o u r n a l P r e -p r o o f screening practices. A recent meta-analysis estimated overall worldwide SARS-CoV-2 seroprevalence at 3.38% (95%CI 3.05-3.72%) (5), noting significant variation with sociodemographic and geographical factors. Another meta-analysis calculated seroprevalence among HCW worldwide at 8.7% (95% confidence interval 6.7-10.9%) (6), indicating a greater risk of infection for HCW compared to the general population. The impact of staff infections at a workplace as well as at an individual level is significant and warrants closer investigation. We conducted a study to determine the prevalence of SARS-CoV-2 antibodies in HCW at Eastern Health, and associations with demographics, work location and role, and exposure to positive cases. A cross-sectional cohort study of HCW at Eastern Health was performed between the 9th November and 4 th December 2020. Ethics was approved by the Eastern Health Human Research Ethics Committee (approval no. LR20/096). Healthcare workers were invited to participate in the study via departmental emails, posters in clinical areas and messaging on the intranet. We defined HCW as any employee within EH, including subcontracted services such as cleaning and catering. Informed consent was embedded into an online survey which required an electronic signature. We estimated that we would need a sample size of 768 to detect a difference of 2% between seroprevalence of high risk workers vs low risk workers with a power of 0.8, alpha of 0.05 and beta of 0.2. This was based on an estimated background seroprevalence in Australia of 1% (7, 8) . The survey During the study period, 736 healthcare workers consented to the study and had blood samples collected. This represents approximately seven percent of the total Eastern Health workforce of 10,400. Of these 736 participants, complete survey responses were available for 706 (96%). Thirteen (2%) reported previous infection with SARS-CoV-2 -six were likely acquired at EH, three were infected elsewhere (known external exposure) and four were unknown. Sixteen (2.17%) participants had reactive antibodies for SARS-CoV-2 by in-house screening (Roche Elecsys immunoassay). All reactive antibodies tested at Eastern Health were completely concordant when tested at VIDRL. Table 1 Of the three participants with positive serology but no previous positive PCR results (3/720, 0.42%), one was an allied health professional who had no previous contact with COVID -19 patients and had returned from the United Kingdom earlier in the year. Two were nurses; one had been identified as a close contact of a positive case and had been furloughed from work for a 14-day period of isolation (remaining asymptomatic and negative by PCR testing during this period); the other had no known contact with any positive cases but had returned from the United Kingdom earlier in the year. Information on the timing of return from travel, and details regarding quarantine following travel were not collected. All three reported that they had experienced symptoms of COVID-19 at some stage in 2020. Factors predicting likelihood of positive serology are also presented in Table 1 The only work group that was associated with a higher odds ratio for seropositivity was cleaning staff (OR 10.5 p=0.004 95%CI: 2.08-52.64). It is important to note that only 12 cleaning staff participated in this study, thus the two who tested positive (representing 17% of this work group) had a significant impact on this analysis. In this study we sampled 736 employees at a tertiary healthcare network in Victoria Australia, including frontline staff as well as non-patient facing and support staff. Based on this sample, we determined the seroprevalence of SARS-CoV-2 antibodies in healthcare workers at Eastern Health to be 2.17%. This was higher than previous estimates of seroprevalence in the Australian community, which ranged from 0.15% to 0.79% (7, 8) , however, these figures, calculated from samples collected prior to the second wave of infections, likely underestimate community seroprevalence. The worldwide estimated seroprevalence in HCW is 8.7% (6), however rates as high as 24.4% have been reported (12) and reflect a spectrum of seropositivity dependent on geographical location and disease prevalence in the community. There have been no community seroprevalence studies conducted in the broader Victorian community to enable accurate comparison, particularly in the context of the second wave of infections. To the authors' knowledge, this is the first HCW seroprevalence study to be published in Australia, and is greatly significant as this reflects not only the low infection rates in the general Australian population, but also emphasises the positive impact of strategies implemented to reduce transmission, both in society, and within healthcare settings. Symptomatic PCR testing, and testing of close contacts and furloughed staff led to the diagnosis of 61 infections with SARS-CoV-2 at EH, out of a workforce of approximately 10,400. This represents an infection rate of 0.59%, lower than the seroprevalence found in this study of 2.17%. We noted however, that the 13 participants in this study previously diagnosed with COVID-19 represented 21% of known EH HCW infections, whereas only J o u r n a l P r e -p r o o f seven percent of the overall workforce participated in our study. Our work mirrors a previous a sero-surveillance study of the general population in Australia and international studies which indicate that a significant proportion of infections are being missed by symptomatic or directed testing (7, 13, 14) . Despite this, our study only identified three HCW with positive serology who had not previously been diagnosed by PCR testing. The diagnostic assay used in this study reports a sensitivity of 99.5% (95% CI 97.0 -100%) in symptomatic patients, and specificity of 99.80% (95% CI 99.69-99.88%) (11) . All participants with confirmed PCR-based diagnoses developed antibodies against SARS-CoV-2, with one participant maintaining these antibodies for 8 months. A previous meta-analysis of SARS-CoV-2 seroprevalence studies associated factors such as work in a COVID-19 unit, patient-related work, and positive household contacts with seropositivity (6) . In our study we found that direct contact with a positive COVID-19 case, or working in a COVID-19 ward, was not associated with an increased likelihood of seropositivity, mirroring HCW seroprevalence studies conducted in the United Kingdom and Germany (12, 15) . This likely reflects the low infection numbers in general nationally. Australia closed its international borders in March 2020, and 13% of participants had returned from overseas countries during the pandemic, including countries with high infection rates such as the United Kingdom, the United States of America and India. Despite this, international travel was not associated with an increased risk of having positive serology. Our study found that having symptoms of COVID-19 was associated with having a 17-fold greater odds of having positive serology. This is not unexpected, as PCR testing was encouraged for anyone with symptoms, no matter how mild. Similar findings have been reported in a HCW seroprevalence study conducted in the United Kingdom (12) . Specific details regarding symptoms for COVID-19 were not collected, such as frequency or timing of symptoms in relation to testing. As such it was not possible to link reported symptoms to PCR or serology test results. Our finding of increased risk of seropositivity associated with having COVID-19 symptoms may therefore be non-specific and cannot be characterised further. Working as a cleaner was associated with higher odds of seropositivity, but this represents only two cleaning staff with reactive antibodies to SARS-CoV-2. Both of these participants had worked at sites that housed COVID-19 patients and had worked on COVID-19 wards. This may indicate a higher risk of COVID-19 infection, potentially due to the rigorous cleaning of contaminated surfaces and spaces or prolonged periods of time in such areas, increasing the risk of breaches to PPE. However, a detailed review of known employee infections at EH revealed that only one of these infections was thought linked to the workplace. Furthermore, only 12 cleaning staff participated in this study, representing 1% of all cleaning staff employed at Eastern Health. In contrast, 373 nurses participated, representing over half of our study participants, and 8% of all nurses employed at our health network. Whilst a clear association between working as a cleaner and SARS-CoV-2 infection cannot be established from our study, this link was demonstrated in another HCW seroprevalence study, where 34.5% of housekeeping staff had reactive antibodies to SARS-CoV-2, higher than the study's overall seroprevalence of 24.4% (12). Due to robust procedures and practices around infection prevention and control locally, high risk exposures such as working on COVID-19 wards were not found to be associated with seropositivity. Other factors that are likely to have contributed to this were the preemptive screening of staff in high risk areas such as emergency departments, and rapid contact tracing processes when staff infections were diagnosed. While this result should be reassuring for HCW at the frontline during this pandemic, the importance of continuing these high standards of infection control as COVID-19 vaccines are rolled out is paramount. This study has several limitations. HCW previously diagnosed with COVID-19 in 2020 were more likely to participate, leading to selection bias. The sample size was also not symmetrical across all work groups and thus may not be truly representative of all HCW in our organisation. Whilst our use of work roles to define exposure risk may not equate with actual exposure risk, this aligns with the methodology used by other HCW seroprevalence studies (15) (16) (17) (18) . Furthermore, our serology testing may have missed cases where antibodies for SARS-CoV-2 had waned prior to sampling, especially if the HCW were asymptomatic or minimally symptomatic (19, 20) , however we did not identify any participants with known COVID-19 diagnoses and negative serology. False positive serology results are also possible but unlikely as all positive results at Eastern Health Pathology were confirmed at VIDRL using a number of different assays. Despite these limitations, this study demonstrates several important findings. Firstly, HCW were found to have a higher rate of SARS-CoV-2 infection than the general population, but the majority of cases had been detected previously by PCR based testing. We found only a J o u r n a l P r e -p r o o f small number of people with positive antibodies that had been missed by workplace efforts to detect and test staff through the pandemic. Even with this likely overestimated seroprevalence of SARS-CoV-2 in HCW at Eastern Health, seropositivity is very low compared to other countries, highlighting Australia's impressive achievement of minimising community and healthcare associated transmission. J o u r n a l P r e -p r o o f Australian Government Department of Health Victorian healthcare worker coronavirus (COVID-19) data 2020 Experts criticise Australia's aged care failings over COVID-19 Australian Health Practitioners Regulation Agency SARS-CoV-2 seroprevalence worldwide: a systematic review and metaanalysis Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and metaanalysis A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting. The Journal of Infectious Diseases Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in The REDCap consortium: Building an international community of software platform partners Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support Elecsys® Anti-SARS-CoV-2 SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States findings from the second nationwide household serosurvey SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients SARS-CoV-2 serosurvey in health care workers of the Veneto Region Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network -13 Academic Medical Centers Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19 The authors would like to thank Kylie Hall and the Infection Prevention and Control team at Eastern Health, as well as the following students from the Eastern Health Clinical School for assistance with coordinating and collecting blood samples; Stephanie Parker, Simran Vinod Ethics approval was obtained from the Eastern Health Human Research Ethics Committee (approval no. LR20/096). This research was funded by an Eastern Health Research and Innovation grant. The researchers were independent from the funder. The authors have no conflicts of interest to disclose. All authors had full access to all of the data in the study. JSYL and SG proposed and designed the study protocol. JSYL and MP performed the data collection. JSYL and PB conducted the analysis. JSYL, PB, RC, SG and EN drafted the manuscript. All authors have reviewed and approved the manuscript prior to submission.A copy of the online staff survey used in this study is available as an appendix. All authors had full access to all of the data in the study. JSYL and SG proposed and designed the study protocol. JSYL and MP performed the data collection. JSYL and PB conducted the analysis. JSYL, PB, RC, SG and EN drafted the manuscript. All authors have reviewed and approved the manuscript prior to submission. Ethics approval was obtained from the Eastern Health Human Research Ethics Committee (approval no. LR20/096).